EVL-I is a splice variant of EVL (Ena/VASP like protein), whose in vivo function and regulation are still poorly understood. We found that Protein Kinase D (PKD) interacts in vitro and in vivo with EVL-I and phosphorylates EVL-I in a 21 amino acid alternately-included insert in the EVH2 domain. Following knockdown of the capping protein CPbeta and spreading on laminin, phosphorylated EVL-I can support filopodia formation and the phosphorylated EVL-I is localized at filopodial tips. Furthermore, we found that the lamellipodial localization of EVL-I is unaffected by phosphorylation, but that impairment of EVL-I phosphorylation is associated with ruffling of lamellipodia upon PDBu stimulation. Besides the lamellipodial and filopodial localization of phosphorylated EVL-I in fibroblasts, we determined that EVL-I is hyperphosphorylated and localized in the cell-cell contacts of certain breast cancer cells and mouse embryo keratinocytes. Taken together, our results show that phosphorylated EVL-I is present in lamellipodia, filopodia and cell-cell contacts and suggest the existence of signaling pathways that may affect EVL-I via phosphorylation of its EVH2 domain.
EVL-I is a splice variant of pan class="Gene">EVL (Ena/VASP like protein), whose in vivo function and regulation are still poorly understood. We found that Protein Kinase D (PKD) interacts in vitro and in vivo with EVL-I and phosphorylates EVL-I in a 21 amino acid alternately-included insert in the EVH2 domain. Following knockdown of the capping protein CPbeta and spreading on laminin, phosphorylated EVL-I can support filopodia formation and the phosphorylated EVL-I is localized at filopodial tips. Furthermore, we found that the lamellipodial localization of EVL-I is unaffected by phosphorylation, but that impairment of EVL-I phosphorylation is associated with ruffling of lamellipodia upon PDBu stimulation. Besides the lamellipodial and filopodial localization of phosphorylated EVL-I in fibroblasts, we determined that EVL-I is hyperphosphorylated and localized in the cell-cell contacts of certain breast cancer cells and mouse embryo keratinocytes. Taken together, our results show that phosphorylated EVL-I is present in lamellipodia, filopodia and cell-cell contacts and suggest the existence of signaling pathways that may affect EVL-I via phosphorylation of its EVH2 domain.
Authors: L M Lanier; M A Gates; W Witke; A S Menzies; A M Wehman; J D Macklis; D Kwiatkowski; P Soriano; F B Gertler Journal: Neuron Date: 1999-02 Impact factor: 17.173
Authors: V Laurent; T P Loisel; B Harbeck; A Wehman; L Gröbe; B M Jockusch; J Wehland; F B Gertler; M F Carlier Journal: J Cell Biol Date: 1999-03-22 Impact factor: 10.539
Authors: L Y Romanova; I A Alexandrov; M V Blagosklonny; R P Nordan; S Garfield; P Acs; P Nguyen; J Trepel; P M Blumberg; J F Mushinski Journal: J Cell Physiol Date: 1999-05 Impact factor: 6.384
Authors: A Aszódi; A Pfeifer; M Ahmad; M Glauner; X H Zhou; L Ny; K E Andersson; B Kehrel; S Offermanns; R Fässler Journal: EMBO J Date: 1999-01-04 Impact factor: 11.598
Authors: Ganesh V Pusapati; Tim Eiseler; An Rykx; Sandy Vandoninck; Rita Derua; Etienne Waelkens; Johan Van Lint; Götz von Wichert; Thomas Seufferlein Journal: J Biol Chem Date: 2012-01-06 Impact factor: 5.157
Authors: Joseph J Abrajano; Irfan A Qureshi; Solen Gokhan; Deyou Zheng; Aviv Bergman; Mark F Mehler Journal: PLoS One Date: 2009-12-07 Impact factor: 3.240
Authors: Heike R Döppler; Ligia I Bastea; Laura J Lewis-Tuffin; Panos Z Anastasiadis; Peter Storz Journal: J Biol Chem Date: 2013-07-11 Impact factor: 5.157